Key result
Huntington's disease links to elevated total huntingtin in plasma extracellular vesicles of transgenic pigs.
Why the study?
Biomarkers to monitor Huntington's disease development and therapy efficacy are needed, and extracellular vesicles are potential carriers of such biomarkers.
Observational
p-value: p=0.02
Huntingtin co-isolates with small extracellular vesicles in blood plasma of HD pig models and patients, suggesting potential as a biomarker for Huntington's disease.
Supports plasma EV huntingtin as candidate HD biomarker; leaves open human validation before clinical consideration.
(1) Background: Huntington’s disease (HD) is rare incurable hereditary neurodegenerative disorder caused by CAG repeat expansion in the gene coding for the protein huntingtin (HTT). Mutated huntingtin (mHTT) undergoes fragmentation and accumulation, affecting cellular functions and leading to neuronal cell death. Porcine models of HD are used in preclinical testing of currently emerging disease modifying therapies. Such therapies are aimed at reducing mHTT expression, postpone the disease onset, slow down the progression, and point out the need of biomarkers to monitor disease development and therapy efficacy. Recently, extracellular vesicles (EVs), particularly exosomes, gained attention as possible carriers of disease biomarkers. We aimed to characterize HTT and mHTT forms/fragments in blood plasma derived EVs in transgenic (TgHD) and knock-in (KI-HD) porcine models, as well as in HD patients’ plasma. (2) Methods: Small EVs were isolated by ultracentrifugation and HTT forms were visualized by western blotting. (3) Results: The full length 360 kDa HTT co-isolated with EVs from both the pig model and HD patient plasma. In addition, a ~70 kDa mutant HTT fragment was specific for TgHD pigs. Elevated total huntingtin levels in EVs from plasma of HD groups compared to controls were observed in both pig models and HD patients, however only in TgHD were they significant (p = 0.02). (4) Conclusions: Our study represents a valuable initial step towards the characterization of EV content in the search for HD biomarkers.
No takes yet. Share an insight, caveat, or question.
Ananbeh et al. (2022) conducted an observational in Huntington's disease. Huntington's disease status vs. Controls was evaluated on Total huntingtin levels in extracellular vesicles from plasma (p=0.02). Huntington's disease status was associated with elevated total huntingtin levels in extracellular vesicles from plasma compared to controls, which was significant in TgHD pigs (p=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: